Target- |
MechanismCell replacements |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with MUVON Therapeutics AG
0 Patents (Medical) associated with MUVON Therapeutics AG
100 Deals associated with MUVON Therapeutics AG
100 Translational Medicine associated with MUVON Therapeutics AG